Men’s Preventive Laboratory Panel

The men’s preventive laboratory panel is a broad set of laboratory tests designed for adult men who want to assess important health indicators before symptoms appear or as part of a periodic health review. It combines blood testing with urinalysis, prostate-related markers and a test for hidden blood in the stool.

The panel can provide information about blood cells, glucose regulation, blood lipids, thyroid function, liver and kidney indicators, pancreatic enzymes, minerals, electrolytes, inflammation, iron stores and selected preventive markers. It does not replace a physical examination, medical history, imaging or specialist evaluation when these are needed.

What the panel includes

The confirmed panel composition includes:

• Blood count and inflammation: complete blood count and C-reactive protein.
• Glucose and metabolic assessment: glucose, HbA1c and uric acid.
• Blood lipid profile: total cholesterol, HDL cholesterol, LDL cholesterol and triglycerides.
• Thyroid indicators: TSH, free T3 and free T4.
• Kidney-related indicators: urea and creatinine.
• Liver, protein and tissue enzymes: AST, ALT, GGT, alkaline phosphatase, LDH, total bilirubin, total serum protein and creatine kinase.
• Pancreatic enzymes: amylase and lipase.
• Minerals, electrolytes and iron status: phosphorus, calcium, potassium, magnesium, sodium, iron and ferritin.
• Prostate-related markers: total PSA and free PSA.
• Urinalysis: urine dipstick and microscopic examination of urine sediment.
• Stool testing: testing for occult, visually undetectable blood in the stool.

What the results may help assess

Blood glucose and HbA1c provide different views of glucose regulation. Glucose reflects the level at the time of collection, while HbA1c reflects average blood glucose over a longer period. Cholesterol fractions and triglycerides contribute to cardiovascular and metabolic risk assessment but must be interpreted together with blood pressure, smoking status, body weight, family history and other clinical factors.

Urea, creatinine, electrolytes and urinalysis can provide information relevant to kidney and urinary system assessment. AST, ALT, GGT, alkaline phosphatase, bilirubin and total protein contribute to evaluation of liver-related patterns. Amylase and lipase are pancreatic enzymes, while creatine kinase may be affected by muscle activity or injury.

TSH, free T3 and free T4 assess different aspects of thyroid function. Iron and ferritin support the assessment of iron availability and stored iron, while the complete blood count can identify patterns that may require further evaluation, including anemia, infection or changes in blood cell counts.

PSA and free PSA limitations

PSA is produced by prostate tissue, but an elevated PSA result does not confirm prostate cancer. PSA can also increase with benign prostate enlargement, inflammation, infection, recent prostate manipulation and some forms of intense physical activity. A result within the reference range cannot completely exclude prostate disease.

Free PSA may provide additional context when interpreted together with total PSA, age, previous PSA values, prostate findings, urinary symptoms and individual risk factors. Neither total PSA nor free PSA should be interpreted as a stand-alone diagnosis. Depending on the result and the individual risk profile, a doctor may recommend repeat testing, clinical examination, imaging or urological assessment.

The decision to use PSA for preventive testing should be individualized. Age, family history, general health, previous results and the potential benefits and disadvantages of further investigation should be considered.

Occult blood in the stool

The stool component checks for small amounts of blood that are not visible to the eye. A positive result does not establish the cause and does not by itself diagnose colorectal cancer. Bleeding may have different explanations, and a positive finding generally requires medical evaluation and may lead to colonoscopy or another diagnostic procedure.

A negative result does not exclude every colorectal condition, particularly when symptoms such as visible bleeding, persistent changes in bowel habits, unexplained weight loss, anemia or abdominal pain are present. Symptoms should be assessed independently of a preventive panel result.

How sample collection works

Blood sample

Venous blood is collected during one blood draw. Different portions of the sample are used for the complete blood count, biochemical measurements, thyroid tests, inflammatory markers and PSA testing.

Urine sample

The recommended specimen is the midstream portion of the first morning urine collected in a sterile container. It should be delivered for analysis as soon as possible.

Stool samples

For occult blood testing, samples are collected from three consecutive bowel movements over three days using three dedicated containers. A small amount is taken from several areas on the surface of each stool sample. The containers are kept refrigerated and submitted after the third sample has been collected.

Preparation before testing

Fasting for 8 to 10 hours is recommended because the panel includes glucose and lipid testing. Plain water may be consumed. Prescribed medication should not be stopped without medical advice. A current medication and supplement list should be provided because some substances can influence individual results.

For reliable PSA measurement, mechanical irritation of the prostate and intense physical activity should be avoided for 72 hours before blood collection. Cycling can temporarily raise PSA. Recent rectal examination, prostate biopsy, prostate procedure or surgery should be reported before testing. PSA should generally be measured before a prostate procedure or at least six weeks after surgery.

No special diet is required for the immunochemical occult blood test. Testing may need to be postponed during diarrhea, active hemorrhoidal bleeding or blood in the urine. Certain medicines can contribute to gastrointestinal bleeding, but they must not be discontinued without instructions from the prescribing doctor.

Understanding the report

The stated laboratory turnaround is generally within three hours after all required samples have been received. The complete process takes longer when stool samples are collected over three consecutive days.

Results are presented with applicable reference intervals, but a value outside the reference range does not automatically mean that a disease is present. Results can be influenced by age, fasting, hydration, medication, supplements, recent illness, physical activity and individual biological variation.

The panel is intended as a preventive assessment and not as a definitive diagnosis. Abnormal results should be reviewed together with symptoms, medical history, physical examination and previous findings. Further testing should be selected according to the specific abnormality rather than automatically repeating or expanding every test.

To arrange the panel, send an inquiry with your age, relevant medical history, current medication, previous laboratory reports and information about any recent prostate examination or procedure. This helps confirm the appropriate preparation and determine whether an additional medical consultation should be organized.